DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 090382
NDA 090382 describes LOSARTAN POTASSIUM, which is a drug marketed by Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Cadista Pharms, Hetero Labs Ltd V, Ipca Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Mylan, Prinston Inc, Sandoz, Teva, Torrent Pharms, Unichem Labs Ltd, Upsher-smith Labs, Viva Hlthcare, Vivimed Global, Watson Labs, West-ward Pharms Int, Zydus Pharms Usa Inc, Apotex, and Teva Pharms, and is included in thirty-six NDAs. It is available from fifty-six suppliers. Additional details are available on the LOSARTAN POTASSIUM profile page.
The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
Summary for 090382
| Tradename: | LOSARTAN POTASSIUM |
| Applicant: | Vivimed Global |
| Ingredient: | losartan potassium |
| Patents: | 0 |
| Therapeutic Class: | Cardiovascular Agents |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 090382
| Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 090382
Suppliers and Packaging for NDA: 090382
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 090382 | ANDA | Heritage Pharmaceuticals Inc. | 23155-644 | N | 23155-644-09 |
| LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 090382 | ANDA | Heritage Pharmaceuticals Inc. | 23155-644 | N | 23155-644-03 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Oct 6, 2010 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Oct 6, 2010 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Oct 6, 2010 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
